Clinical Trial Update: Fenofibrate and Metformin Fixed Combination vs Rosiglitazone - FAME ROSI [Phase 3]

View source ↗

Summary

Phase 3 trial comparing fenofibrate/metformin fixed-dose combination with rosiglitazone in patients with dyslipidemia and impaired glucose metabolism; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• Fenofibrate/metformin fixed-dose combination
• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Dyslipidemia, Glucose Metabolism Disorder | Phase 3 | Status: TERMINATED